Price Alert

Exagen Inc. (XGN)

NASDAQ: XGN · Real-Time Price · USD

9.66

0.31 (3.37%)

At close: Aug 15, 2025, 12:52 PM

3.37% (1D)

Bid	9.57
Market Cap	212.55M
Revenue (ttm)	58.86M
Net Income (ttm)	-16.98M
EPS (ttm)	-0.89
PE Ratio (ttm)	-10.85
Forward PE	-24.16
Analyst	Buy

Ask	11.66
Volume	192,362
Avg. Volume (20D)	294,753
Open	9.45
Previous Close	9.35
Day's Range	9.01 - 9.66
52-Week Range	2.38 - 9.75
Beta	1.62

About XGN

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol XGN

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for XGN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Exagen Inc. is scheduled to release its earnings on Nov 11, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

3 months ago

-9.81%

Exagen shares are trading lower after the company ... Unlock content with Pro Subscription

News

2 weeks ago · seekingalpha.com

Exagen Inc. (XGN) Q2 2025 Earnings Call Transcript

Exagen Inc. (NASDAQ:XGN ) Q2 2025 Earnings Conference Call July 29, 2025 8:30 AM ET Company Participants Jeffrey G. Black - CFO & Corporate Secretary John Aballi - CEO, President & Director Ryan Dougl...

2 weeks ago · fool.com

Exagen Q2 Revenue Jumps 14 Percent

2 weeks ago · zacks.com

Exagen Inc. (XGN) Reports Q2 Loss, Beats Revenue Estimates

Exagen Inc. (XGN) came out with a quarterly loss of $0.18 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.16 per share a year ago.

3 weeks ago · zacks.com

Exagen (XGN) Soars 5.5%: Is Further Upside Left in the Stock?

Exagen (XGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in th...